Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.12B |
| 2 |
Amazon
AMZN
|
+$606M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$542M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$409M |
| 5 |
Apple
AAPL
|
+$302M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.23B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.41B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$935M |
| 5 |
DuPont de Nemours
DD
|
+$669M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.63% |
| 2 | Financials | 5.94% |
| 3 | Consumer Discretionary | 5% |
| 4 | Communication Services | 4.96% |
| 5 | Healthcare | 4.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Old National Bancorp
ONB
$10.3B
| $3.03M | ﹤0.01% |
182,752
-16,025
| -8% | -$245K |
|
|
DCH
1902
Dauch Corp
DCH
$1.38B
| $3.02M | ﹤0.01% |
362,347
-28,797
| -7% | -$217K |
|
1903
CRISPR Therapeutics
CRSP
$4.88B
| $3.02M | ﹤0.01% |
19,747
+6,390
| +48% | +$755K |
|
1904
PUT
NovoCure
NVCR
$1.78B
| $3.01M | ﹤0.01% |
17,400
| – | – |
|
1905
Jefferies Financial Group
JEF
$12.8B
| $3.01M | ﹤0.01% |
128,026
+86,363
| +207% | +$1.81M |
|
1906
PUT
Burlington
BURL
$23.2B
| $3.01M | ﹤0.01% |
11,500
| – | – |
|
|
AMED
1907
DELISTED
Amedisys
AMED
| $3M | ﹤0.01% |
10,223
+873
| +9% | +$224K |
|
1908
National Grid
NGG
$80.3B
| $3M | ﹤0.01% |
57,443
+30,531
| +113% | +$1.62M |
|
1909
Prosperity Bancshares
PB
$9.02B
| $3M | ﹤0.01% |
43,239
-3,658
| -8% | -$224K |
|
|
MNDT
1910
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $3M | ﹤0.01% |
130,064
-1,308
| -1% | -$20.1K |
|
1911
Brady Corp
BRC
$4.52B
| $2.99M | ﹤0.01% |
56,626
-1,799
| -3% | -$79.5K |
|
1912
Western Alliance Bancorporation
WAL
$9.04B
| $2.99M | ﹤0.01% |
49,902
+31,041
| +165% | +$1.51M |
|
1913
Frontline
FRO
$8.88B
| $2.98M | ﹤0.01% |
478,021
+248,824
| +109% | +$1.6M |
|
1914
OGE Energy
OGE
$9.79B
| $2.97M | ﹤0.01% |
93,336
-17,403
| -16% | -$562K |
|
1915
PUT
Tenet Healthcare
THC
$20.1B
| $2.97M | ﹤0.01% |
74,400
| – | – |
|
1916
Xencor
XNCR
$1.44B
| $2.97M | ﹤0.01% |
68,012
-62,471
| -48% | -$2.58M |
|
|
SAVE
1917
DELISTED
Spirit Airlines, Inc.
SAVE
| $2.95M | ﹤0.01% |
120,866
-86,848
| -42% | -$1.8M |
|
|
FBC
1918
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $2.95M | ﹤0.01% |
72,498
-28,200
| -28% | -$972K |
|
|
AAT
1919
American Assets Trust
AAT
$1.47B
| $2.95M | ﹤0.01% |
102,251
-12,890
| -11% | -$343K |
|
1920
STAAR Surgical
STAA
$1.21B
| $2.95M | ﹤0.01% |
37,223
-19,030
| -34% | -$1.39M |
|
1921
CALL
Seagate
STX
$189B
| $2.95M | ﹤0.01% |
47,400
-73,900
| -61% | -$4.15M |
|
1922
iPath Select MLP ETN
ATMP
$635M
| $2.94M | ﹤0.01% |
251,875
-348,163
| -58% | -$3.8M |
|
1923
CareTrust REIT
CTRE
$9.74B
| $2.93M | ﹤0.01% |
132,298
-21,553
| -14% | -$424K |
|
|
HEP
1924
DELISTED
Holly Energy Partners, L.P.
HEP
| $2.93M | ﹤0.01% |
206,532
-4,954
| -2% | -$64.3K |
|
1925
First Solar
FSLR
$25B
| $2.93M | ﹤0.01% |
29,610
-139,414
| -82% | -$12.1M |
|
Similar funds
Barclays's Q4 2020 Portfolio in Review
As of Q4 2020, Barclays held 5,338 positions worth $189B, up 12% from $168B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays's Q4 2020 filing shows 130 new, 1,373 increased, 2,436 reduced and 454 closed positions. Its largest new stake was FTAI Aviation: 2,107,800 shares worth $42.2M. The largest sale was Visa, an estimated $2.23B.
By sector, the portfolio is most concentrated in Technology at 9.6% of assets, up from 8.9% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q4 2020 buy was FTAI Aviation: 2,107,800 shares worth $42.2M.
- Barclays added most to iShares US Real Estate ETF in Q4 2020, an estimated $1.12B increase.
- Barclays's biggest Q4 2020 reduction was Visa, cutting an estimated $2.23B.
- Barclays fully exited Noble Energy, Inc. in Q4 2020, selling an estimated $167M.
- Barclays's ten largest holdings make up 35% of its $189B portfolio in Q4 2020.
- Barclays opened 130 new positions and closed 454 in Q4 2020.
- Barclays's portfolio value rose 12% quarter-over-quarter to $189B.
Based on Barclays's 13F filing for Q4 2020, filed 11 Feb 2021.